The limitations of calcineurin and mTOR inhibitors: new directions for immunosuppressive strategies

Publisher： Elsevier

ISSN： 0041-1345

Source： Transplantation Proceedings, Vol.34, Iss.1, 2002-02, pp. : 130-133

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

mTOR Inhibition and the Tumor Vasculature

Current Angiogenesis, Vol. 1, Iss. 1, 2012-04 ,pp. : 11-19

Bentham Science Publishers

Access to resources Recommend Favorite

Sarcoidosis News: Immunologic Frontiers for New Immunosuppressive Strategies

By Agostini C. Costabel U. Semenzato G.

Clinical Immunology, Vol. 88, Iss. 2, 1998-08 ,pp. : 199-204

Academic Press

Access to resources Recommend Favorite

Hypothalamic mTOR: The Rookie Energy Sensor

Current Molecular Medicine, Vol. 14, Iss. 1, 2014-01 ,pp. : 3-21

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanism of action of the calcineurin inhibitors

By Halloran P.F.

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3067-3069

Elsevier

Access to resources Recommend Favorite

On the horizon: clinical trials of new immunosuppressive strategies for autoimmune diseases

By Daikh D.I. Wofsy D.

Transplantation Proceedings, Vol. 30, Iss. 8, 1998-12 ,pp. : 4027-4028

Elsevier

Access to resources Recommend Favorite